Found: 6
Select item for more details and to access through your institution.
Relapse after allogeneic hematopoietic cell transplantation for multiple myeloma (MM): Single center experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e273, doi. 10.1016/j.clml.2019.09.450
- By:
- Publication type:
- Article
Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma.
- Published in:
- Connecticut Medicine, 2015, v. 79, n. 7, p. 401
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 415, doi. 10.1007/s11899-017-0404-z
- By:
- Publication type:
- Article
Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 887, doi. 10.1111/bjh.19244
- By:
- Publication type:
- Article
Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 48, doi. 10.1002/hon.2946
- By:
- Publication type:
- Article